Personalized Genetics: Weekend Summary Part Two November 3, 2007
Posted by Bertalan Meskó in 1000$ Genome, Genome, Personalized medicine, genetics.trackback
This is the second part of this weekend’s summary about personalized genetics.
- Mapping a Genome and a Life (US News): An interesting interview with Craig Venter.
What will be your genome’s impact?
I think this genome sequence will serve as a reference for the start of individualized medicine. We hope that by next year we’ll have 30 to 50 additional genomes and that eventually we’ll get at least 10,000. Once we create databases of many individuals’ genomes, we can start to sort out nature and nurture and give people information that can help them prevent disease.
- Testing-testing: drug dosing based on SNPs? (Pathtalk): A perfect explanation of FDA’s Warfarin story.
- The Fortune Cookie Genome (Public Rambling): A fantastic, imaginary story
- Third complete human genome sequenced (PHG Foundation)
- Robin’s Market Blog: Response Genetics Plans to Make Available Its ERCC-1 Molecular Diagnostic Test for Platin-Based Chemotherapy Resistance in the First Quarter of 2008
- 2x genomes—Does depth matter? (Genome Research): Cats enter the genomic era.
- Are you a cat genome person or a dog genome person? (Genomicron)
Let’s finish this edition with a quote from George Church featured by Eye on DNA:
If you have cancer predisposition, you can get early diagnosis. You can get a mastectomy so you remove the tissue that’s likely to cause trouble. For stomach cancer, for colon cancer, there are various things that people do in advance. Or, you could [find out you] have a bad drug reaction, [and] you could just never take that class of drugs or food.
[...] way more than I can handle). One of the best sources are his personalized genetics summaries. In a recent one he points to a quote from George Church (via Eye on DNA) If you have cancer predisposition, you [...]
[...] And on Scienceroll, I continued my series about the best posts of personalized genetics in this weekend’s summary part one and part two. [...]